Cargando…

Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the NACC Database

INTRODUCTION: As the identification of Lewy body dementia (LBD) is often confirmed postmortem, there is a paucity of evidence on the progression of disease antemortem. This study aimed to comprehensively assess the course of LBD over time across cognitive, functional, and neuropsychiatric outcomes u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandler, Julie, Georgieva, Mihaela, Desai, Urvi, Kirson, Noam, Lane, Henry, Cheung, Hoi Ching, Westermeyer, Ben, Biglan, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837351/ https://www.ncbi.nlm.nih.gov/pubmed/36378462 http://dx.doi.org/10.1007/s40120-022-00417-w

Ejemplares similares

Validation of the National Alzheimer's Coordinating Center (NACC) Lewy Body Disease Module neuropsychological tests
por: Rahman‐Filipiak, Annalise, et al.
Publicado: (2022)

Characteristics of patients misdiagnosed with Alzheimer’s disease and their medication use: an analysis of the NACC-UDS database
por: Gaugler, Joseph E, et al.
Publicado: (2013)

Faster Cognitive and Functional Decline in Dysexecutive versus Amnestic Alzheimer's Subgroups: A Longitudinal Analysis of the National Alzheimer's Coordinating Center (NACC) Database
por: Mez, Jesse, et al.
Publicado: (2013)

Response to van Dyck, O'Dell, & Mecca letter to the editor regarding Andrews et al. (2019)
por: Andrews, J. Scott, et al.
Publicado: (2023)

Excess Costs Associated with Possible Misdiagnosis of Alzheimer’s Disease Among Patients with Vascular Dementia in a UK CPRD Population
por: Happich, Michael, et al.
Publicado: (2016)

Portuguese version of the CDR plus NACC FTLD: Validation studies
por: Lima, Marisa, et al.
Publicado: (2022)

Disease severity at the time of initial cognitive assessment is related to prior health‐care resource use burden
por: Desai, Urvi, et al.
Publicado: (2020)

Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies
por: Chen, Qin, et al.
Publicado: (2022)

Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo‐Controlled Trial
por: Biglan, Kevin, et al.
Publicado: (2021)

Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia
por: Battioui, Chakib, et al.
Publicado: (2023)

Trends in health service use and potentially avoidable hospitalizations before Alzheimer's disease diagnosis: A matched, retrospective study of US Medicare beneficiaries
por: Desai, Urvi, et al.
Publicado: (2019)

Factor Consistency of Neuropsychological Test Battery Versions in the NACC Uniform Data Set
por: Culhane, Jessica E., et al.
Publicado: (2020)

Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan
por: Hadjiyianni, Irene, et al.
Publicado: (2016)

Functional limitations and health care resource utilization for individuals with cognitive impairment without dementia: Findings from a United States population-based survey
por: Andrews, J. Scott, et al.
Publicado: (2016)

Association between Motor Signs and Cognitive Performance in Cognitively Unimpaired Older Adults: A Cross-Sectional Study Using the NACC Database
por: Siokas, Vasileios, et al.
Publicado: (2022)

Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration
por: Kantarci, Kejal, et al.
Publicado: (2022)

Reduced Expression of Slc Genes in the VTA and NAcc of Male Mice with Positive Fighting Experience
por: Smagin, Dmitry A., et al.
Publicado: (2021)

Parental perspectives of episodic irritability in an ultra-rare genetic disorder associated with NACC1
por: Schoch, Kelly, et al.
Publicado: (2023)

An intellectual-disability-associated mutation of the transcriptional regulator NACC1 impairs glutamatergic neurotransmission
por: Daniel, James A., et al.
Publicado: (2023)

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
por: Andrews, J. Scott, et al.
Publicado: (2019)

Evaluating the Use of Digital Biomarkers to Test Treatment Effects on Cognition and Movement in Patients with Lewy Body Dementia
por: Wang, Jian, et al.
Publicado: (2022)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

Dementia with Lewy bodies
por: McKeith, Ian
Publicado: (2004)

Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials
por: Goldman, Jennifer G., et al.
Publicado: (2020)

Delusions in Patients with Dementia with Lewy Bodies and the Associated Factors
por: Tzeng, Ray-Chang, et al.
Publicado: (2018)

A Longitudinal Study of Neurocognition in Dementia with Lewy Bodies Compared to Alzheimer’s Disease
por: Breitve, Monica H., et al.
Publicado: (2018)

Reliability of the NACC Telephone‐administered Neuropsychological Battery (T‐cog) and Montreal Cognitive Assessment for participants in the USC ADRC
por: Howard, Rebecca Sitra, et al.
Publicado: (2023)

Identification of a NACC1-Regulated Gene Signature Implicated in the Features of Triple-Negative Breast Cancer
por: Ngule, Chrispus M., et al.
Publicado: (2023)

Caffeine Consumption and Dementia: Are Lewy Bodies the Link?
por: Cornelis, Marilyn C., et al.
Publicado: (2022)

The experience of a severe hypoglycaemic event from the perspective of people with diabetes and their caregivers: “What am I going to do?”
por: Stuckey, Heather L., et al.
Publicado: (2021)

Neuroimaging in Lewy body dementia
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Microbleeds in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2020)

Advances in dementia with Lewy bodies
por: Armstrong, Melissa J.
Publicado: (2021)

Neuroimaging in Dementia With Lewy Bodies
por: Saha, Abhishikta, et al.
Publicado: (2021)

Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting
por: Goldman, Jennifer G., et al.
Publicado: (2021)

Amplification of The ch19p13.2 NACC1 Locus in Ovarian High-grade Serous Carcinoma
por: Shih, Ie-Ming, et al.
Publicado: (2011)

A longitudinal study of anxiety and cognitive decline in dementia with Lewy bodies and Alzheimer’s disease
por: Breitve, Monica H., et al.
Publicado: (2016)

Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies
por: Mak, Elijah, et al.
Publicado: (2015)

Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer’s Disease
por: Kirson, Noam Y., et al.
Publicado: (2017)

Neuroimaging characteristics of dementia with Lewy bodies
por: Mak, Elijah, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_br79db4funvbj8g22bivh18reg